Klaria Pharma Holding AB (publ.) (STO:KLAR)
Sweden · Delayed Price · Currency is SEK 0.7880
+0.0080 (1.03%)
Jul 24, 2026, 5:24 PM CET
STO:KLAR Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.12 | 9.03 | 2.33 | 0.23 | 6.54 | 37.52 | |
Revenue Growth (YoY) | -98.97% | 288.31% | 920.18% | -96.51% | -82.58% | 369.16% |
Gross Profit | 0.12 | 9.03 | 2.33 | 0.23 | 6.54 | 37.52 |
Selling, General & Admin | 13.98 | 14.16 | 11.43 | 10.44 | 10.16 | 9.86 |
Research & Development | 21.55 | 28.3 | 22.11 | 4.45 | 51.36 | 63.49 |
Other Operating Expenses | - | - | - | - | - | 14.28 |
Total Operating Expenses | 35.53 | 42.46 | 33.53 | 14.89 | 61.51 | 87.63 |
Operating Income | -35.42 | -33.43 | -31.21 | -14.67 | -54.97 | -50.11 |
Interest Income | - | 0 | 0.01 | 0.01 | 0 | -3.44 |
Interest Expense | - | -13.63 | -16.53 | -3.78 | -8.69 | - |
Other Non-Operating Income (Expense) | -10.53 | - | - | - | - | - |
Total Non-Operating Income (Expense) | -10.53 | -13.63 | -16.53 | -3.78 | -8.68 | -3.44 |
Pretax Income | -45.95 | -47.06 | -47.73 | -18.44 | -63.66 | -53.55 |
Provision for Income Taxes | - | 0 | 0.02 | -0.06 | 0.12 | -0.01 |
Net Income | -37.3 | -47.06 | -47.75 | -35.78 | -63.77 | -53.53 |
Earnings From Discontinued Operations | - | - | - | -17.4 | 0 | - |
Net Income to Common | -45.95 | -47.06 | -47.75 | -35.78 | -63.77 | -53.53 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 214 | 189 | 125 | 101 | 58 | 52 |
Shares Outstanding (Diluted) | 215 | 189 | 125 | 101 | 58 | 52 |
Shares Change (YoY) | 60.24% | 51.58% | 23.63% | 73.49% | 12.15% | 19.58% |
EPS (Basic) | -0.25 | -0.25 | -0.38 | -0.36 | -1.10 | -1.03 |
EPS (Diluted) | -0.25 | -0.25 | -0.38 | -0.36 | -1.10 | -1.03 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -36.04 | -34.2 | -11.91 | -9.06 | -49.77 | -24.8 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.17 | -0.18 | -0.10 | -0.09 | -0.86 | -0.48 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -30797.40% | -370.10% | -1341.66% | -6432.02% | -840.97% | -133.56% |
Profit Margin | -32430.40% | -521.02% | -2052.88% | -15694.70% | -975.59% | -142.69% |
FCF Margin | -31340.00% | -378.69% | -511.91% | -3972.81% | -761.37% | -66.09% |
EBITDA | -24.24 | -22.21 | -19.99 | -3.63 | -43.94 | -39.14 |
EBITDA Margin | -21081.70% | -245.88% | -859.33% | -1591.23% | -672.17% | -104.33% |
EBIT | -35.42 | -33.43 | -31.21 | -14.67 | -54.97 | -50.11 |
EBIT Margin | -30797.40% | -370.10% | -1341.66% | -6432.02% | -840.97% | -133.56% |
Effective Tax Rate | - | 0.00% | -0.04% | 0.31% | -0.18% | 0.02% |